ARCHIVES

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 42 | November 11, 2011

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

Obama Signs Spending Bill for FY09

March 13, 2009

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007